UNSPSC 85672713: Supplement left trunk bursa and ligament with synthetic substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left trunk bursa and ligament with synthetic substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0MUD4JZ

UNSPSC 85672713 (Supplement left trunk bursa and ligament with synthetic substitute, percutaneous endoscopic approach), a Commodity code, shows no recent state and local procurement activity aligned with its clinical procedural scope. The six recent opportunities posted under this code span independent medical evaluation services for public safety retirement determinations, surgical benefit carve-out programs, occupational medical surveillance, emergency and specialty healthcare for detained youth, pharmacy benefit management, and temporary health professional staffing—none of which involves orthopedic joint supplementation procedures or related surgical implants. The code does not reflect what state and local governments are actually buying in current solicitations, and pursuing vendors in medical device or orthopedic implant supply should treat this code as inactive for present business development purposes.

The mismatch between code classification and actual procurement activity suggests either a taxonomy misalignment in the source data or an artifact of how one or more issuing bodies tagged their opportunities. The recent opportunities originate from a mix of city retirement offices, municipal HR departments, state transportation agencies, county juvenile justice systems, and county health systems across Arizona, California, Washington, and Florida—all procuring administrative, staffing, and benefit management services rather than surgical consumables or implants. Until state and local solicitations explicitly address joint supplementation supplies or procedures under this code, there is insufficient market signal to warrant active pursuit.